Latest AI and machine learning research in lung cancer for healthcare professionals.
Though critical, traditional diagnostic approaches such as X-ray, CT scans, bronchoscopy and tissue biopsy don't reliably detect lung cancer at early stages, paradigm shift has occurred recently with lung cancer diagnostics based on recent advances of molecular biology and computational technologies. Present review analyses incorporation of molecular biomarkers- EGFR, ALK, KRAS, BRAF, MET and PD-L...
INTRODUCTION: Cancer is a major global health concern, causing millions of deaths each year due to the uncontrolled growth and spread of abnormal cell...
Accurate elemental decomposition in dual-energy computed tomography (DECT) is crucial for precision in radiation therapy planning. We present a compar...
To assess how computed tomography (CT) image reconstruction techniques affect perceived diagnostic image quality at varying radiation dose levels in c...
While neutrophils represent a prominent myeloid component in non-small cell lung cancer (NSCLC), the specific immunosuppressive functions of N2-polari...
ObjectiveThis study aims to develop a functional-based multi-omics model for early prediction of radiation pneumonitis (RP) by extracting radiomic and...
Lung cancer, the leading cause of global cancer-related mortality, is categorized into small-cell and non-small-cell subtypes. The heterogeneous non-s...
Accurate authentication of rice geographical origin is crucial for food safety and fraud prevention. Synchrotron radiation X-ray fluorescence (SR-XRF)...
PURPOSE: We present MuTriM, a multimodal deep learning model integrating DCE-MRI and whole-slide pathology to predict survival and radiation benefit i...
BACKGROUND: Non-small cell lung cancer (NSCLC) is a common type of lung cancer with poor prognosis and high mortality in advanced stages. Although sec...
Lung and Colon Cancer (LCC) is a prevalent type of cancer influenced by factors such as genetics, smoking, second-hand smoke exposure, and alcohol con...
BACKGROUND: Brain metastasis (BrM) is a leading cause of mortality in patients with lung adenocarcinoma (LUAD). Extracellular vesicles (EVs), which ca...
BACKGROUND: The molecular landscape of lung adenocarcinoma (LUAD) is often illustrated as a driver-oncogene "pie chart," but identical mutations exhib...
Gastric cancer (GC) risk is shaped by environmental exposures such as benzo[a]pyrene (BaP). Here, we systematically identified BaP-toxicological targe...
OBJECTIVE: To identify the optimal super-resolution (SR) architecture for radiomics by comparing three models (Residual Channel Attention Network (RCA...
Small cell lung cancer (SCLC) is a highly aggressive tumor with poor prognosis. Ferroptosis is closely linked to tumor antigen presentation: it affect...
Radiation skin injury (RSI) is an unavoidable side effect of radiotherapy that delays the treatment process and affects patients' quality of life. How...